ALM Share Price Performance
ALM Community Fair Values
- €12.90FV20.6% undervalued intrinsic discount10.49%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative8users have followed this narrative11 days ago author updated this narrative
Recent ALM News & Updates
No updates
Almirall, S.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 10, 2025
- Earnings per share (EPS)
- 0.099
- Gross Margin
- 76.05%
- Net Profit Margin
- 2.02%
- Debt/Equity Ratio
- 23.4%
Almirall, S.A. Competitors
About ALM
- Founded
- 1943
- Employees
- 2084
- CEO
- WebsiteView website
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Spanish Market Performance
- 7 Days: -1.2%
- 3 Months: 3.4%
- 1 Year: 25.2%
- Year to Date: 16.6%
Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.9% in the Consumer Discretionary sector. In the last year, the market is actually up 25%. Earnings are forecast to grow by 4.6% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading